[topsearch__bar__shortcode]

April 18, 2022

CTK

CooTek (Cayman) Inc. (CTK) Rebounds After Hours Following a Steep Fall. What Happened?

On April 14, the mobile apps and AI tech developer with hands in the metaverse, CooTek (Cayman) Inc. (CTK) stock rebounded in the after hours. This rebound came after a fall of over 10% in regular trading. Thus after closing the regular session at $0.2051, CTK soared to reach $0.2200 per share in the after […]

CooTek (Cayman) Inc. (CTK) Rebounds After Hours Following a Steep Fall. What Happened? Read More »

INDO

Indonesia Energy Corp. Ltd. (INDO) Under Corrections After Upward Rally

April 14 proved to be another bright day for crude oil and gas stocks. Like most oil and gas stocks, the Jakarta-based Indonesia Energy Corp. Ltd. (INDO) also witnessed an upswing on Friday. But the stock soon succumbed to corrections after registering gains of 65.93% during the regular session. Thus, following its shot up to

Indonesia Energy Corp. Ltd. (INDO) Under Corrections After Upward Rally Read More »

HUSA Stock

Stock Corrections: Houston American Energy Corp. (HUSA)’s another Rally and another Downfall

On April 14, Houston American Energy Corp. (HUSA) saw another upsurge which was soon followed by corrections in the after hours. It seems investors are trying to make some more profits from the stock. During the regular session, HUS shot up by 38.46% to reach $4.86 a share. Following this, the stock fell under corrections

Stock Corrections: Houston American Energy Corp. (HUSA)’s another Rally and another Downfall Read More »

NVIV stock

InVivo Therapeutics Holdings Corp. (NVIV) stock Tumbles Further Down on Reverse Stock Split

On April 14, the biomaterials and biotech company, InVivo Therapeutics Holdings Corp. (NVIV) announced a reverse split of its common stock by the ratio of 1-for-25 along with a proportionate reduction in its authorized shares. Reacting negatively to the news, investors escalated the ongoing selloff in the stock. Thus, after losing 12.27% during regular trading,

InVivo Therapeutics Holdings Corp. (NVIV) stock Tumbles Further Down on Reverse Stock Split Read More »

NKTR stock

Nektar Therapeutics (NKTR) Takes another Blow on another Key Cancer Drug Clinical Trial

On April 14, Nektar Therapeutics (NKTR) jointly announced with Bristol Myers Squibb (BMY) to drop the global clinical development program for key cancer drug bempegaldesleukin (BRMPRG) in combination with Opdivo. Consequently, shares of NKTR plunged down by 17.05% in the after-hours on Friday to reach $5.11. This downfall came after a slight decline of 0.16%

Nektar Therapeutics (NKTR) Takes another Blow on another Key Cancer Drug Clinical Trial Read More »